- Waking up from the Summer Slumber
M&A activity sparks a summer rally in biotech.
August 22, 2008 - Business - Finance
- Genentech Rebuffs Roche
A discussion from KQED-FM's Forum
August 17, 2008 - Business - Dealmaking
- Meds For Heads
More than 300 drugs in development for mental illnesses ranging from Alzheimer's disease to alcoholism.
August 14, 2008 - Business - Drug Development
- A Magic Formula
Big Pharma may have finally figured out the secret recipie for preserving innovation in the biotechs it acquires.
August 01, 2008 - Business - Dealmaking
- Sign Of The Times
Healthcare sector M&A activity soars in the second quarter.
July 11, 2008 - Business - Finance
- The Urge To Merge
The tough IPO market has made M&A a more likely exit strategy for venture-backed companies.
July 03, 2008 - Business - Finance
- The Knowledge Economy
Massachusetts is best poised to leverage its science and technology assets for economic gains, Milken says.
June 19, 2008 - Business - Economic Development
- Dealing Drugs
The total value of partnering deals fell slightly to $22 billion in 2007, but the pace continued to be brisk.
May 22, 2008 - Business - Dealmaking
- The Marriage Game
M&A Activity slowed a bit in 2007, but the forces driving it continue.
April 24, 2008 - Business - Finance
- Rising in the East
The United States is still the largest pharmaceutical market, but the biggest sales growth is in Asia.
April 17, 2008 - Business - Global Economy
- Providing a Moral Compass
A review of Science Lessons: What the Business of Biotech Taught Me About management by Gordon Binder and Philip Bashe (Harvard Business School Press, 304 pages, $29.95).
April 01, 2008 - DAVID GOLLAHER - Business - Business Strategy
- A Bitter Pill
Pharmaceutical sales rise at their slowest pace since 1961.
March 20, 2008 - Business - Markets
- Touched by an Angel
Risk-taking investors have grown a tad more conservative.
February 27, 2008 - Business - Finance
- Tee Time for Biotech
San Diego's industry insiders find the links can be as good for business as the labs.
February 22, 2008 - ANNE BURKE - Business - Business Development
- Getting Hitched
Partnering deals accounted for nearly half of the $45 billion biotech raised in 2007.
February 14, 2008 - Business - Finance
- Fast Follower
Lead Therapeutics hopes to leverage its chemical expertise and low-cost talent in China to build better molecules cheaper.
February 05, 2008 - DANIEL S. LEVINE - Business - Business Strategy
- PHOTO ESSAY: Tee Time for Biotech
San Diego's industry insiders find the links can be as good for business as the labs.
February 01, 2008 - ANN JOHANSSON - Business - Business Development
- Strange Bedfellows
Mainland China pharma companies have been IPO darlings, but are investors overlooking market weaknesses?
January 31, 2008 - K.C. SWANSON - Business - Finance
- Beyond Generics
Indian pharma and biotech companies look abroad to acquire scientific and market know-how.
January 28, 2008 - SEEMA SINGH - Business - Global Economy
- Blood Simple
Trellis Bioscience is pursuing several preclinical candidates, but its antibody discovery engine is where its star power lies.
January 25, 2008 - DANIEL S. LEVINE - Business - Drug Development
- Eye on the Street
The latest news and numbers from Wall Street.
January 22, 2008 - Business - Markets
- Eye on the Street
The latest news and numbers from Wall Street.
January 22, 2008 - Business - Markets
- Heading East
Big Pharma is shelling out big bucks in China's much of it going to world-class research centers.
January 18, 2008 - K.C. SWANSON - Business - Drug Development
- Food for Thought
A Colorado company takes a novel approach to treating Alzheimer's disease - and to getting its therapy to market.
January 16, 2008 - DANIEL S. LEVINE - Business - Business Strategy
- Measuring Up
The market capitalization of public biotechnology companies is catching up to big pharma despite acquisitions.
January 16, 2008 - Business - Finance
- Scenes from a Life Sciences Conference
With the JPMorgan Healthcare Conference over, industry executives have to head home to deliver on their promises.
January 10, 2008 - DANIEL S. LEVINE - Business - Finance
- The Class of 2007
The industry raised $2 billion, but more than half of the issues finished below water by the end of the year.
January 10, 2008 - Business - Finance
- Taking Pulses
Against a turbulent start for financial markets, the JPMorgan conference launches the new year for the biotechnology sector with optimism.
January 06, 2008 - DANIEL S. LEVINE - Business - Finance
- Ready for Prime Time
Pacific Growth Equities adds a regenerative medicine analyst to its roster.
January 04, 2008 - Business - Finance
- PODCAST: January 2008
December 31, 2007 - Business - Global Economy
- A Rising Tide
Base salaries for life science executives at privately-held companies rose 5.9 percent in 2007.
December 31, 2007 - Business - Finance
- A Different Approach to Parkinson's
Two separate efforts could lead to a new class of drugs to treat the neurodegenerative condition.
December 21, 2007 - DANIEL S. LEVINE - Business - Dealmaking
- Arming the War on Cancer
Nearly 650 new drugs in development in the oncology pipeline to fuel the fight.
December 18, 2007 - Business - Drug Development
- The Device Economy
Report highlights the financial contributions of the medical technology industry
December 13, 2007 - Business - Economic Development
- An Ounce of Prevention
Changing reimbursement rules promise to create demand for product with a once dim future.
December 10, 2007 - DANIEL S. LEVINE - Business - Drug Development
- Dead Meat
Biotech and pharma companies that don't embrace a new model of business are destined to become irrelevant.
December 07, 2007 - G. STEVEN BURRILL, DUANE ROTH, and DAVE JOHNSON - Business - Drug Development
- A Fledgling Drug-making Process
Which came first, the chicken or the biopharmaceutical factory?
December 06, 2007 - SUZANNE ELVIDGE - Business - Drug Development
- Brandjacked
Online scams threaten top-selling drugs, report says
December 05, 2007 - Business - Global Economy
- Bullish on Bio
A visit to EuroBio reveals the Continent still lags in biotech funding. But there's no lack of innovation, and a changing culture may soon fix the financing problem.
November 08, 2007 - FRANK BROWNING - Business - Finance
- No Silver Bullet
Researchers aren't terribly hopeful yet about finding a cure for Alzheimer's, but progress on detection and therapeutics could lead to more effective treatments.
November 06, 2007 - APRIL LYNCH - Business - Drug Development
- Targeted Chemotherapy
Genentech looks to build a drug delivery platform with its monoclonal antibodies, and technology to link them to potent cancer drugs.
November 05, 2007 - DANIEL S. LEVINE - Business - Drug Development
- Bucking the Trend
The IPO fundraising tally is up in 2007 and blockbuster partnering deals continue, but other types of financing were lackluster.
October 31, 2007 - Business - Finance
- A Turning Point
Maxygen has followed a biological model when it comes to its organization, but now investors and company brass want to see results.
October 26, 2007 - CHRIS MEYER AND JOAN CHU - Business - Business Strategy
- RX For Stroke Victims: Irish Coffee - Iced
A San Diego company believes a mixture of caffeine and alcohol along with its cooling technology might minimize damage to the brain when the flow of blood becomes blocked.
October 22, 2007 - DANIEL S. LEVINE - Business - Drug Development
- Suite Deal
Efforts to lure venture capitalists to San Diego are ramping up, but can America's self-proclaimed "finest city" become a VC center of its own?
October 19, 2007 - DANIEL S. LEVINE - Business - Finance
- VIDEO: The Stem Cell Summit
Selected sessions from the event held October 2-3, 2007 in Boston, Massachusetts hosted by Genetics Policy Institute, Harvard Stem Cell Institute and Burrill Life Sciences Media Group.
October 18, 2007 - Business - Finance
- Rewiring the Brain
Companies are racing to develop implantable devices that may finally treat the most stubborn cases depression.
October 17, 2007 - SARAH KLEIN - Business - Medical Devices
- Searching for a Better Morphine
Better understanding of pain's pathways are leading to promising ways for treating chronic and acute pain.
October 15, 2007 - LAWRENCE M. FISHER - Business - Drug Development
- Investing in the Future
The pharmaceutical sector passes the high-tech industry as the leading spender on research and development
October 11, 2007 - Business - Global Economy
- A Funny Thing Happened On The Way To The Forum
Money is flowing more freely into the biotech sector, but investors remain selective as BIO kicks off its annual investor conference.
October 10, 2007 - Business - Finance
- Making Chemo Irresistible
A virtual biopharma has a late-stage cancer drug with an encouraging safety profile that may be able to turn chemo-resistant cancer cells vulnerable.
October 05, 2007 - DANIEL S. LEVINE - Business - Drug Development
- PODCAST
October 2007
October 02, 2007 - Business - Business Strategy
- The Biomolecular Economy
Editor's Letter
October 01, 2007 - WILLIAM PATRICK - Business - Business Strategy
- An Injection of Hope
A vaccine in tests for one rare form of cancer has patients living more than twice as long as those treated by radiation and chemotherapy.
October 01, 2007 - BRUCE GOLDMAN - Business - Drug Development
- Houston, We Have a Problem
Texas' biggest city has a huge medical industry but a small biotech scene. But now institutional partnerships are hoping to change that.
October 01, 2007 - ELLEN DURCKEL - Business - Economic Development
- Variations on a Theme
Crohn's discovery points to the power of a Canadian company's approach to unraveling genetic players in complex diseases.
September 12, 2007 - DANIEL S. LEVINE - Business - Finance
- Getting Down to Business
Osiris has shifted its focus from research to developing products. A stem cell therapy for bones is already on the market and a therapy for treating transplant complications could be next.
September 01, 2007 - By Mark Ratner - Business - Business Strategy
- Spot's Little Helper
Canines need drugs, too. The trick is getting pharma to pay attention.
September 01, 2007 - By Varese Layzer - Business - Business Strategy
- A Hardware Store for the 21st Century
Invitrogen has prospered by providing kits and reagents to make life easier at the lab. Supplying the needs of stem cell researchers is the next frontier.
September 01, 2007 - By William Patrick - Business - Business Strategy
- Pfizer Alters Its DNA
As key products come off patent, the drug giant looks to biologics to help build its future.
August 29, 2007 - DANIEL S. LEVINE - Business - Drug Development
- Gathering Steam
IPO market heats up in the first half of the year, but many issues didn't fare well.
August 13, 2007 - Business - Finance
- Power Shift
Asia is set to become not only the largest pharmaceutical market, but its territories will be important industry hubs.
August 08, 2007 - DANIEL S. LEVINE - Business - Global Economy
- VCs Big On Bio
Second quarter investment in biopharmaceuticals once again leads healthcare sector
August 06, 2007 - Business - Finance
- VCs Invest Healthy Amounts in Medical Devices
Second quarter investment in the sector tops $1 billion, a 58 percent jump from a year ago.
July 30, 2007 - Business - Finance
- Delivering the Goods
$1 billion RNAi deal heats up sector, but hurdles for the technology remain.
July 12, 2007 - DANIEL S. LEVINE - Business - Drug Development
- True Romance
Genentech shows it can attract a big pharma partner to take role traditionally played by smaller biotechs.
June 27, 2007 - DANIEL S. LEVINE - Business - Dealmaking
- Expiring Revenue
Leading pharmaceutical companies face substantial hits to the top line with patents set to expire.
June 18, 2007 - Business - Drug Development
- Debating Evolution
PriceWaterhouseCoopers sees the global pharmaceutical market doubling to $1.3 trillion by 2020, but says industry will have to change to capitalize on opportunities.
June 14, 2007 - DANIEL S. LEVINE - Business - Business Strategy
- Betting on Growth
Obesity seen as big investment opportunity in the years ahead.
June 11, 2007 - Business - Finance
- Innovation Gap Widens
June 11, 2007 - Business - Drug Development
- Music To Their Ears
MP3-like device retrains brain to ignore tinnitus
May 30, 2007 - DANIEL S. LEVINE - Business - Medical Devices
- Sherlock Meets The Other Dr. Watson
Applied Biosystems sees growth opportunities in databases of DNA samples from criminals.
May 23, 2007 - DANIEL S. LEVINE - Business - Business Strategy
- Flu Bugged
A small Australian biotech takes on a drug giant over a soured influenza drug alliance.
May 22, 2007 - DANIEL S. LEVINE - Business - Dealmaking
- Buying Bio
Why Florida's ambitions aren't costing Southern California any sleep.
May 08, 2007 - JOE PANETTA - Business - Economic Development
- Inventing the Future
Billionaire David Murdock is trying to turn Kannapolis, North Carolina, into a boom town for biotech.
May 08, 2007 - DANIEL S. LEVINE - Business - Economic Development
- Genentech's Joe McCracken Is On the Hunt
Biotech giant's top dealmaker says he's focusing on early-stage drugs.
May 07, 2007 - Business - Dealmaking
- Healthy Couture
Clothes that protect health professionals from bacteria and agricultural workers from pesticides may be coming soon.
August 17, 2007 - ERIC WAHLGREN - Health - Innovation
- Simple Math
Pharma should partner with industry in developing nations to create cost-scaled markets within the world's emerging economies.
July 21, 2007 - LISA CONTE - Health - Global Health
- Let Science Dictate Research
Congress should help build on researchers' stem cell momentum.
June 07, 2007 - JONATHAN C. MORENO and SAM BERGER - Health - Regenerative Medicine
